8-KEarnings & ResultsExhibits & Filings

ABBOTT LABORATORIES 8-K Report, Financial Results (Oct 17, 2012)

Filed October 17, 2012For Securities:ABT

Summary

Abbott Laboratories (ABT) filed an 8-K on October 17, 2012, to announce its third-quarter 2012 financial results. The filing primarily serves to furnish a press release detailing these results, which includes the use of non-GAAP financial measures. These non-GAAP figures are presented to offer investors a clearer view of ongoing business performance by excluding unusual or unpredictable items such as acquisition and separation costs, litigation reserves, R&D impairments, and restructuring charges. Management utilizes these non-GAAP measures internally for performance monitoring and believes they provide valuable insights for investors. However, the company emphasizes that these measures should be considered alongside, and not as a substitute for, traditional GAAP financial reporting. Investors should refer to the furnished press release for the specific financial details and reconciliations.

Key Highlights

  • 1Abbott Laboratories announced its third-quarter 2012 financial results via an 8-K filing.
  • 2The filing primarily furnished a press release containing the Q3 2012 earnings announcement.
  • 3Abbott utilized non-GAAP financial measures, including adjusted net earnings and diluted earnings per share, in its Q3 reporting.
  • 4These non-GAAP measures exclude items such as acquisition-related costs, separation costs, litigation reserves, R&D impairments, and restructuring charges.
  • 5Management believes these non-GAAP metrics offer a better evaluation of ongoing business performance.
  • 6Investors are advised to consider non-GAAP measures in conjunction with, not as a replacement for, GAAP financial measures.
  • 7The press release is included as Exhibit 99.1 to the 8-K filing.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce Abbott Laboratories' financial results for the third quarter of 2012. It includes a press release with detailed earnings information and the use of non-GAAP financial measures.

Non-GAAP financial measures are financial metrics that exclude certain items from the standard GAAP (Generally Accepted Accounting Principles) figures. Abbott uses them to provide investors with a clearer picture of ongoing business performance by excluding unusual or unpredictable items like acquisition costs, litigation reserves, and restructuring charges. Management also uses these measures internally.

No, investors should not rely solely on the non-GAAP financial measures. Abbott's management advises that these measures should be considered in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP. The press release should contain reconciliations to GAAP figures.

The detailed third-quarter 2012 financial results are provided in the press release furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to that document for specific financial figures and any accompanying analysis or reconciliations.